Sun Pharmaceutical Industries Ltd. closed 12.97% below its 52-week high of 1,960.20 rupees, which the company achieved on ...

Stay updated with the Sun Pharma Stock Liveblog, your one-stop destination for real-time information and analysis of a ...

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

Sun Pharmaceutical Industries Limited has announced the completion of its 100% acquisition of Antibe Therapeutics Inc., a ...

Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...

The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...

Analysts expect Sun to continue to be more aggressive in chasing speciality assets, but a successful launch is necessary for ...

Sun Pharma and Zydus Pharmaceuticals recall products in the US due to manufacturing issues, according to the US FDA. The ...

Sun Pharmaceutical Industries Ltd. closed 10.79% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

The NJEDA Board approved tax credits under the Emerge Program to support Sun Pharmaceutical Industries Inc.’s plan to open a ...

Shares of Marksans Pharma were trading higher in the afternoon session on Tuesday, up 2.14% at ₹207.2 per piece on the BSE at ...